These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29944336)
1. Structural Basis of Small Molecule Targetability of Monomeric Tau Protein. Kiss R; Csizmadia G; Solti K; Keresztes A; Zhu M; Pickhardt M; Mandelkow E; Tóth G ACS Chem Neurosci; 2018 Dec; 9(12):2997-3006. PubMed ID: 29944336 [TBL] [Abstract][Full Text] [Related]
2. Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies. Pickhardt M; Neumann T; Schwizer D; Callaway K; Vendruscolo M; Schenk D; St George-Hyslop P; Mandelkow EM; Dobson CM; McConlogue L; Mandelkow E; Tóth G Curr Alzheimer Res; 2015; 12(9):814-28. PubMed ID: 26510979 [TBL] [Abstract][Full Text] [Related]
3. Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble. Zhu S; Shala A; Bezginov A; Sljoka A; Audette G; Wilson DJ PLoS One; 2015; 10(3):e0120416. PubMed ID: 25767879 [TBL] [Abstract][Full Text] [Related]
4. Intrinsically disordered tau protein in Alzheimer's tangles: a coincidence or a rule? Skrabana R; Skrabanova M; Csokova N; Sevcik J; Novak M Bratisl Lek Listy; 2006; 107(9-10):354-8. PubMed ID: 17262987 [TBL] [Abstract][Full Text] [Related]
5. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation. Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680 [TBL] [Abstract][Full Text] [Related]
6. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design. Wang D; Huang X; Yan L; Zhou L; Yan C; Wu J; Su Z; Huang Y Protein J; 2021 Oct; 40(5):656-668. PubMed ID: 34401998 [TBL] [Abstract][Full Text] [Related]
7. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins. Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286 [TBL] [Abstract][Full Text] [Related]
8. A functional role for intrinsic disorder in the tau-tubulin complex. Melo AM; Coraor J; Alpha-Cobb G; Elbaum-Garfinkle S; Nath A; Rhoades E Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14336-14341. PubMed ID: 27911791 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's-disease-associated conformation of intrinsically disordered tau protein studied by intrinsically disordered protein liquid-phase competitive enzyme-linked immunosorbent assay. Skrabana R; Skrabanova-Khuebachova M; Kontsek P; Novak M Anal Biochem; 2006 Dec; 359(2):230-7. PubMed ID: 17081491 [TBL] [Abstract][Full Text] [Related]
10. Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling. Murugan NA; Nordberg A; Ågren H ACS Chem Neurosci; 2018 Jul; 9(7):1757-1767. PubMed ID: 29630333 [TBL] [Abstract][Full Text] [Related]
11. Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies. Altendorf T; Gering I; Santiago-Schübel B; Aghabashlou Saisan S; Tamgüney G; Tusche M; Honold D; Schemmert S; Hoyer W; Mohrlüder J; Willbold D Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768484 [TBL] [Abstract][Full Text] [Related]
12. Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis. Skrabana R; Sevcik J; Novak M Cell Mol Neurobiol; 2006; 26(7-8):1085-97. PubMed ID: 16779670 [TBL] [Abstract][Full Text] [Related]
13. Secondary structures transition of tau protein with intrinsically disordered proteins specific force field. Dan A; Chen HF Chem Biol Drug Des; 2019 Mar; 93(3):242-253. PubMed ID: 30259679 [TBL] [Abstract][Full Text] [Related]
14. Modulation and detection of tau aggregation with small-molecule ligands. Chang E; Honson NS; Bandyopadhyay B; Funk KE; Jensen JR; Kim S; Naphade S; Kuret J Curr Alzheimer Res; 2009 Oct; 6(5):409-14. PubMed ID: 19874263 [TBL] [Abstract][Full Text] [Related]
15. β-Sheet core of tau paired helical filaments revealed by solid-state NMR. Daebel V; Chinnathambi S; Biernat J; Schwalbe M; Habenstein B; Loquet A; Akoury E; Tepper K; Müller H; Baldus M; Griesinger C; Zweckstetter M; Mandelkow E; Vijayan V; Lange A J Am Chem Soc; 2012 Aug; 134(34):13982-9. PubMed ID: 22862303 [TBL] [Abstract][Full Text] [Related]
16. Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. Hochgräfe K; Sydow A; Matenia D; Cadinu D; Könen S; Petrova O; Pickhardt M; Goll P; Morellini F; Mandelkow E; Mandelkow EM Acta Neuropathol Commun; 2015 May; 3():25. PubMed ID: 25958115 [TBL] [Abstract][Full Text] [Related]
17. Liquid-Liquid Phase Separation of Tau Protein Is Encoded at the Monomeric Level. Dong X; Bera S; Qiao Q; Tang Y; Lao Z; Luo Y; Gazit E; Wei G J Phys Chem Lett; 2021 Mar; 12(10):2576-2586. PubMed ID: 33686854 [TBL] [Abstract][Full Text] [Related]
18. Characterization of two VQIXXK motifs for tau fibrillization in vitro. Li W; Lee VM Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091 [TBL] [Abstract][Full Text] [Related]
19. Initiation of assembly of tau(273-284) and its ΔK280 mutant: an experimental and computational study. Larini L; Gessel MM; LaPointe NE; Do TD; Bowers MT; Feinstein SC; Shea JE Phys Chem Chem Phys; 2013 Jun; 15(23):8916-28. PubMed ID: 23515417 [TBL] [Abstract][Full Text] [Related]
20. Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies. Bakota L; Ussif A; Jeserich G; Brandt R Mol Cell Neurosci; 2017 Oct; 84():132-141. PubMed ID: 28318914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]